In soft-tissue sarcomas, a recent meta-analysis analyzing 551 patients with different types of sarcomas demonstrated that activation of the ALT mechanism was strongly associated with an increased risk of mortality (doubled risk of mortality, HR = 2.02) [11•]. The gene discussed is GPT; the disease is soft tissue sarcoma.